Kailera Therapeutics, Inc.
KLRA
$14.83
-$0.02-0.10%
NASDAQ
| 06/30/2026 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Net Income | -41.14% | -60.97% | |||
| Total Depreciation and Amortization | 0.00% | -1.59% | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | 132.83% | 86.20% | |||
| Change in Net Operating Assets | 257.92% | 236.69% | |||
| Cash from Operations | -13.49% | -44.12% | |||
| Capital Expenditure | -- | -- | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -2,599.12% | -36.25% | |||
| Cash from Investing | -2,599.12% | -36.25% | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | 1,173,352.63% | -- | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | 39.35% | -- | |||
| Cash from Financing | 22,483.42% | -- | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | 138.14% | 99.45% | |||